Preparation method of water-soluble phytosterol nano-dispersion system with intestinal targeted release function

US11058693B1 · US · B1

Patent metadata
FieldValue
Publication numberUS-11058693-B1
Application numberUS-202017001241-A
CountryUS
Kind codeB1
Filing dateAug 24, 2020
Priority dateMar 24, 2020
Publication dateJul 13, 2021
Grant dateJul 13, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention discloses a method for preparing a water-soluble phytosterol nano-dispersion system with intestinal targeted release function, which comprises the following steps: preparing a phytosterol solution; preparing an ethanol aqueous solution containing pectin; then adding zein to obtain a zein pectin solution; mixing the phytosterol solution and the zein pectin solution by means of ultrasonic treatment to obtain a nanoparticle dispersion liquid; rotavaping the nano-particle dispersion liquid to remove ethanol and water to obtain a zein/pectin loaded phytosterol nano-dispersion system. In this invention, not only an ultrasonic method and an anti-solvent method are adopted, but also a pectin component is added with zein as an entrapping agent, which ensures an effective entrapping of phytosterol by zein while further facilitating to form a more compact interface structure and improving a stability of the nano-dispersion system.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for preparing a water-soluble phytosterol nano-dispersion system with intestinal targeted release function, wherein the phytosterol is stigmasterol, wherein the method comprises the following steps: (1) dissolving the stigmasterol in absolute ethanol to obtain a stigmasterol solution; (2) pre-dissolving pectin in deionized water, and then adding with ethanol to obtain an ethanol aqueous solution containing pectin; adding zein into the ethanol aqueous solution to obtain a zein pectin solution, wherein a mass ratio of pectin to zein is 1:10; (3) mixing the stigmasterol solution in the step (1) and the zein pectin solution in the step (2) by means of ultrasonic treatment to obtain a nanoparticle dispersion liquid; (4) rotavaping the nanoparticle dispersion liquid to remove the organic solvent and water to obtain a water-soluble stigmasterol nano-dispersion system. 2. The method for preparing a water-soluble phytosterol nano-dispersion system with intestinal targeted release function according to claim 1 , wherein the ethanol aqueous solution in step (2) contains 80-90% ethanol by volume. 3. The method for preparing a water-soluble phytosterol nano-dispersion system with intestinal targeted function according to claim 1 , wherein in the step (3), the ultrasonic treatment conditions are as follows: a continuous ultrasonic treatment using a probe ultrasonic processor with an ultrasonic frequency of 15-25 kHz, a power of 150-250 W, and a lasted time of 1-3 min. 4. The method for preparing a water-soluble phytosterol nano-dispersion system with intestinal targeted function according to claim 3 , wherein after the continuous ultrasonic treatment is finished, the ultrasonic treatment is continued with a pulse mode, with a pulse frequency of 1 pulse per second and a lasted time of 0.5˜1.5 min. 5. The method for preparing a water-soluble phytosterol nano-dispersion system with intestinal targeted function according to claim 1 , wherein in the nanoparticle dispersion liquid in the step (3), a mass ratio of stigmasterol, pectin and zein is 1:0.5:5. 6. The method for preparing a water-soluble phytosterol nano-dispersion system with intestinal targeted function according to claim 1 , wherein in the step (4), a temperature for the rotavaping is 40-50° C., with a rotating speed of 50-60 rpm.

Assignees

Inventors

Classifications

  • Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin · CPC title

  • Proteins, e.g. albumin, gelatin · CPC title

  • Dispersions; Emulsions · CPC title

  • A61K31/575Primary

    substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol · CPC title

  • Plant sterols or derivatives thereof, e.g. phytosterols · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11058693B1 cover?
The invention discloses a method for preparing a water-soluble phytosterol nano-dispersion system with intestinal targeted release function, which comprises the following steps: preparing a phytosterol solution; preparing an ethanol aqueous solution containing pectin; then adding zein to obtain a zein pectin solution; mixing the phytosterol solution and the zein pectin solution by means of ultr…
Who is the assignee on this patent?
Zhengjiang Univ Of Technology, Univ Zhejiang Technology
What technology area does this patent fall under?
Primary CPC classification A61K31/575. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jul 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).